Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)

Clinical trial NCT00261287 · COMPLETED

Trial details

NCT number: NCT00261287
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hay Fever Perennial Allergic Rhinitis

Start date: 2005-11-01
Primary completion: 2006-06-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.